Brief: BioRestorative Therapies Got Unanimous Recommendation To Proceed Phase 2 Trial For Chronic Lumbar Disc Disease, BRTX-100
July 7 (Reuters) - BioRestorative Therapies Inc
BRTX.O :
* BIORESTORATIVE THERAPIES - GOT UNANIMOUS RECOMMENDATION TO
PROCEED PHASE 2 TRIAL FOR CHRONIC LUMBAR DISC DISEASE, BRTX-100
* BIORESTORATIVE THERAPIES -THERE WERE NO SEVERE ADVERSE
EVENTS
THAT WERE CORRELATED TO DOSE LIMITING TOXICITY( DLTS)
Further company coverage: BRTX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM